Conditions: Acne Vulgaris
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 210
Healthy volunteers: no

Brief summary:
Safety and Efficacy of IDP-123 Lotion (0.045% tazarotene) to Tazorac® (tazarotene) Cream, 0.1%, in the Treatment of Acne Vulgaris

Detailed description:
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Study to Compare the Safety and Efficacy of IDP-123 Lotion (0.045% tazarotene) to Tazorac® (tazarotene) Cream, 0.1%, in the Treatment of Acne Vulgaris

Arms:
arm 1: Lotion arm 2: Cream arm 3: Lotion arm 4: Cream

Interventions: intervention 1: IDP-123 Lotion intervention 2: Tazorac Cream intervention 3: Vehicle Lotion intervention 4: Vehicle Cream
Intervention descriptions: intervention 1: Lotion intervention 2: Cream intervention 3: Lotion intervention 4: Cream

Protocol document: